A Curious Case of Ureteral Obstruction in a 15-Year-Old Female

Abstract

Get full access to this article

View all access options for this article.

References

Stone

Zen

Deshpande

IgG4-related disease. N Engl J Med. 2012;366:539-551.

Brito-Zeron

Ramos-Casals

Bosch

Stone

JH.

The clinical spectrum of IgG4- related disease. Autoimmun Rev. 2014;13:1203-1210.

Hamano

Kawa

Horiuchi

. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-738.

Kamisawa

Okamoto

IgG4-related sclerosing disease. World J Gastroenterol. 2008;14:3948-3955.

Cheuk

Chan

JK.

IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol. 2010;17:303-332.

Mannion

Cron

RQ.

Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature. Pediatr Rheumatol Online J. 2011;9(1):1. doi:10.1186/1546-0096-9-1.

Khosroshahi

Stone

JH.

A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:57-66.

Islam

Selmi

Datta-Mitra

. The changing faces of IgG4-related disease: clinical manifestations and pathogenesis. Autoimmun Rev. 2015;14:914-922.

Cheuk

Yuen

Chu

Chiu

Lam

Chan

JK.

Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:671-681.

10.

Khosroshahi

Bloch

Deshpande

Stone

JH.

Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62:1755-1762.